Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension

NCT00660179 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

742

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: macitentan (ACT-064992)
DRUG: macitentan (ACT-064992)
DRUG: placebo

Sponsor

Actelion